Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Enhancing the reproducibility of serological methods used to evaluate immunogenicity of pandemic H1N1 influenza vaccines-an effective EU regulatory approach.

Wagner R, Göpfert C, Hammann J, Neumann B, Wood J, Newman R, Wallis C, Alex N, Pfleiderer M.

Vaccine. 2012 Jun 8;30(27):4113-22. doi: 10.1016/j.vaccine.2012.02.077. Epub 2012 Mar 22.

PMID:
22446639
2.

Correlates of protection to influenza virus, where do we go from here?

Cox RJ.

Hum Vaccin Immunother. 2013 Feb;9(2):405-8. Epub 2013 Jan 4. Review.

3.

Overview of Serological Techniques for Influenza Vaccine Evaluation: Past, Present and Future.

Trombetta CM, Perini D, Mather S, Temperton N, Montomoli E.

Vaccines (Basel). 2014 Oct 13;2(4):707-34. doi: 10.3390/vaccines2040707. Review.

4.

Summary of knowledge gaps related to quality and efficacy of current influenza vaccines.

Pfleiderer M, Trouvin JH, Brasseur D, Gränstrom M, Shivji R, Mura M, Cavaleri M.

Vaccine. 2014 Jul 31;32(35):4586-91. doi: 10.1016/j.vaccine.2014.05.027. Epub 2014 Jun 20. Review.

PMID:
24954696
5.

Controlling equine influenza: Traditional to next generation serological assays.

Kinsley R, Scott SD, Daly JM.

Vet Microbiol. 2016 May 1;187:15-20. doi: 10.1016/j.vetmic.2016.03.006. Epub 2016 Mar 10. Review.

PMID:
27066704
6.

[New era of laboratory testing. Topics: I. Generals; 3. Applications of mass spectrometry to laboratory medicine].

Nomura F.

Nihon Naika Gakkai Zasshi. 2013 Dec 10;102(12):3096-102. Review. Japanese. No abstract available.

PMID:
24605556
7.

Assaying the Potency of Influenza Vaccines.

Minor PD.

Vaccines (Basel). 2015 Feb 5;3(1):90-104. doi: 10.3390/vaccines3010090. Review.

Items per page

Supplemental Content

Write to the Help Desk